Clinical utiliy of a model-based piperacillin dose in neonates with early-onset sepsis.
Yue-E WuShan-Shan HouZeng-Yu FangBo-Hao TangBu-Fan YaoYi-Ning DongXue LiHai-Yan ShiYi ZhengGuo-Xiang HaoXin HuangJohn Van Den AnkerYong-Hui YuWei ZhaoPublished in: British journal of clinical pharmacology (2021)
A model-based dosing regimen of piperacillin/tazobactam was evaluated clinically, was tolerated well and was determined to be effective for EOS treatment.